Screener
Nuvation Bio NUVB Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Liability related to revenue interest financing agreement, current portion | 12,999 | 9,585 |
| Short-term borrowings | 5,893 | 5,724 |
| Warrant liability | — | 2,865 |
| Accrued expenses | 45,204 | 45,183 |
| Total current liabilities | 86,755 | 82,231 |
| Contract liabilities, net of current portion | 8,228 | 11,305 |
| Non-current operating lease liabilities | 1,910 | 2,543 |
| Non-current liability related to revenue interest financing agreement, net of deferred financing costs of $3,818 and $4,241, respectively | 151,122 | 145,819 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's accrued expenses?
- Nuvation Bio (NUVB) reported accrued expenses of $45.2M in Q2 2026.
- How has Nuvation Bio's accrued expenses changed year-over-year?
- Nuvation Bio's accrued expenses increased by 88.4% year-over-year, from $24M to $45.2M.
- What is the long-term trend for Nuvation Bio's accrued expenses?
- Over 5 years (2020 to 2025), Nuvation Bio's accrued expenses has grown at a 59.5% compound annual growth rate (CAGR), from $4.38M to $45.18M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Nuvation Bio's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude